EdgarLookup

ADAPTIN BIO, INC. — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ADAPTIN BIO, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 ($1.68M) Nov 14, 2025
Q3 2025 Jun 30, 2025 ($1.52M) Nov 14, 2025
Q2 2025 Jun 30, 2025 ($1.52M) Aug 14, 2025
Q1 2025 Mar 31, 2025 ($603.1K) May 15, 2025
Q2 2025 Mar 31, 2025 ($603.1K) Aug 14, 2025
Q3 2025 Mar 31, 2025 ($603.1K) Nov 14, 2025
Q3 2025 Sep 30, 2024 ($1.11M) Nov 14, 2025
Q3 2025 Jun 30, 2024 ($818.7K) Nov 14, 2025
Q2 2025 Jun 30, 2024 ($818.7K) Aug 14, 2025
Q3 2025 Mar 31, 2024 ($339.4K) Nov 14, 2025
Q1 2025 Mar 31, 2024 ($339.4K) May 15, 2025
Q2 2025 Mar 31, 2024 ($339.4K) Aug 14, 2025
Q3 2024 Sep 30, 2023 ($42.9K) Nov 14, 2024
Q2 2024 Jun 30, 2023 ($4.3K) Aug 14, 2024
Q3 2024 Jun 30, 2023 ($4.3K) Nov 14, 2024
Q1 2024 Mar 31, 2023 ($4.3K) May 15, 2024
Q2 2024 Mar 31, 2023 ($4.3K) Aug 14, 2024
Q3 2024 Mar 31, 2023 ($4.3K) Nov 14, 2024
Q3 2023 Sep 30, 2022 ($4.3K) Nov 14, 2023
Q3 2023 Jun 30, 2022 ($4.3K) Nov 14, 2023

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 ($1.68M) Nov 14, 2025
Q2 2025 Jun 30, 2025 ($1.52M) Aug 14, 2025
Q1 2025 Mar 31, 2025 ($850.5K) May 15, 2025
Q3 2025 Sep 30, 2024 ($994.7K) Nov 14, 2025
Q2 2025 Jun 30, 2024 ($767.3K) Aug 14, 2025
Q1 2025 Mar 31, 2024 ($299.7K) May 15, 2025
Q3 2023 Sep 30, 2023 ($42.9K) Nov 14, 2023
Q3 2023 Sep 30, 2022 ($4.3K) Nov 14, 2023